Sponsor pipeline

Toll Biotech Co. Ltd. (Beijing) clinical trial pipeline

Get alerts when Toll Biotech Co. Ltd. (Beijing)'s trials change

2 active trials 1 recruiting 2 disease areas 3 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

What changed in the last 30 days

2026-10-02
Interventions modified
Trial sites reduced: 6 → 1 locations
Trial arms changed: 2 → 4
NCT07408024 Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis · Phase 2

Active trials by phase

Phase 2
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT07408024 Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis Rheumatoid Arthritis (RA) Recruiting 2026-10-01
NCT07745725 A Phase II Study of TollB-001 Tablets in Systemic Sclerosis Systemic Sclerosis (SSc) Not Yet Recruiting 2026-08-04

Disease areas by active trials

Rheumatoid Arthritis (1) · Scleroderma (1)

Get alerts when Toll Biotech Co. Ltd. (Beijing)'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free